Skip to main content

. 1995 Dec 16;311(7020):1631–1634. doi: 10.1136/bmj.311.7020.1631

ABC of atrial fibrillation. Drugs for atrial fibrillation.

G Y Lip ¹, R D Watson ¹, S P Singh ¹

PMCID: PMC2551512 PMID: 8555811

1631

Images in this article

p1631-a
on p.1631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Channer K. S. The drug treatment of atrial fibrillation. Br J Clin Pharmacol. 1991 Sep;32(3):267–273. doi: 10.1111/j.1365-2125.1991.tb03898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Coplen S. E., Antman E. M., Berlin J. A., Hewitt P., Chalmers T. C. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990 Oct;82(4):1106–1116. doi: 10.1161/01.cir.82.4.1106. [DOI] [PubMed] [Google Scholar]
Cowan J. C. Antiarrhythmic drugs in the management of atrial fibrillation. Br Heart J. 1993 Oct;70(4):304–306. doi: 10.1136/hrt.70.4.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
Juul-Möller S., Edvardsson N., Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 1990 Dec;82(6):1932–1939. doi: 10.1161/01.cir.82.6.1932. [DOI] [PubMed] [Google Scholar]
Lip G. Y., Metcalfe M. J., Rae A. P. Management of paroxysmal atrial fibrillation. Q J Med. 1993 Aug;86(8):467–472. doi: 10.1093/qjmed/86.8.467. [DOI] [PubMed] [Google Scholar]
Reiffel J. A., Estes N. A., 3rd, Waldo A. L., Prystowsky E. N., DiBianco R. A consensus report on antiarrhythmic drug use. Clin Cardiol. 1994 Mar;17(3):103–116. doi: 10.1002/clc.4960170303. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES